Patients pick the app by name and trust it with their health. That name deserves more protection than an app-store listing.
In healthtech, the brand is the trust layer. A patient booking a 2 a.m. video consult is not reading your compliance certifications — they are trusting a name on an app icon. Doctor networks run on the same logic in reverse: clinics and physicians join a platform because the brand brings them patients. When lookalike apps appear in the store with a near-identical name, they are not stealing downloads. They are stealing trust, and in this category trust is the product.
The legal frame: telemedicine and medical services sit in Class 44, the downloadable app in Class 9, and the platform or SaaS layer that hospitals and doctors use in Class 42. One TM-A application costs ₹4,500 per class for startups, MSMEs and individuals — ₹9,000 otherwise. India is first-to-file, and healthtech names face stricter scrutiny than most, so the search and the filing both matter more here.
Three filings cover most of the IP risk on day one. Each is a standalone service and each links to a deeper walkthrough.
Healthtech combines the copycat problems of consumer apps with the naming sensitivities of pharma. Three patterns cause most of the damage.
All three risks shrink to nearly zero with a clearance search, an early filing and a standard licence for network partners.
Healthtech founders often file Class 9 for the app and stop. The revenue usually says otherwise.
A typical telemedicine platform files Class 44 + 9 + 42 together. Map your own stack with the class finder before filing day.
Two sections of the Trade Marks Act do most of the filtering here. Section 9 rejects descriptive names — a brand that is essentially “online doctor consult” in Sanskrit or English will struggle as a mark, however good it sounds in a pitch deck. Section 11 blocks names confusingly similar to earlier marks, and in the medical space examiners and courts apply that test strictly.
Practical naming rules we give healthtech founders: avoid names that sound like drug brands or borrow pharma suffixes; avoid cure-implying words that can also trip advertising law for health claims; prefer coined or arbitrary names, which clear the register faster and enforce more cleanly. Run a proper trademark search across Class 44, 9, 42 and Class 5 — the pharma class — before you commit, because the conflict that kills a healthtech name usually lives in Class 5.
Remember the regulatory overlay runs parallel to the trademark: telemedicine practice guidelines govern how doctors consult on your platform, and India's data-protection law governs the health data you hold. The brand promise and the compliance posture have to match — regulators and patients will check both.
Government fees: ₹4,500 per class for startups, MSMEs and individuals; ₹9,000 otherwise. A DPIIT-recognised healthtech startup filing Class 44 + 9 + 42 pays ₹13,500 in government fees — roughly one month of a single performance-marketing campaign, for an asset that lasts 10 years and renews forever.
Filing takes 48 hours and the ™ goes up immediately. Examination follows within months; healthtech marks draw objections more often than average because of crowded health-adjacent registers, and an objection gives you 30 days to reply. After acceptance, the mark publishes in the Journal for a 4-month opposition window, then registers — 7–18 months end to end for a clean file.
Running a telehealth or healthtech brand? Send us the name — we will check Class 44, 9, 42 and the pharma register before you file.
WhatsApp our team →Class 44, which covers medical and healthcare services including remote consultations. Most platforms also file Class 9 for the downloadable app and Class 42 for the SaaS or platform layer used by doctors and hospitals.
Both, usually. The downloadable app patients install is a Class 9 good; the hosted platform, dashboards and APIs behind it are Class 42 services. If doctors consult patients under your brand, add Class 44 as the core service class.
Because confusion between medical brands can harm patients, not just businesses. Indian courts, following the Supreme Court's approach in the Cadila case, apply a stricter similarity test to medicinal and health-related marks, and examiners follow suit. A thorough pre-filing search matters more in this category than almost any other.
Yes, but only under a written licence with quality-control terms. Uncontrolled use of your mark by network clinics on signboards and prescriptions can weaken the mark and complicate enforcement. A standard short-form licence for every network partner keeps ownership clean.
₹4,500 per class in government fees for DPIIT-recognised startups, MSMEs and individuals (₹9,000 otherwise). The typical three-class filing — Class 44, 9 and 42 — costs ₹13,500 in government fees for a startup, plus professional charges.